Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,411 institutions that hold shares in the stock, with a total of 88.7 Million shares, which have been reported (via 13F filing form) to have a value of $49.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
9,424,048
shares
|
$5.24 Billion
0.08% of portfolio
|
Q2 2025
Added 0.17%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,446,366
shares
|
$4.7 Billion
0.2% of portfolio
|
Q2 2024
Reduced 1.43%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
5,658,197
shares
|
$3.15 Billion
0.28% of portfolio
|
Q1 2025
Reduced 19.85%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,832,002
shares
|
$2.69 Billion
0.1% of portfolio
|
Q2 2025
Added 0.88%
|
|
|
Dodge & Cox
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
3,826,283
shares
|
$2.13 Billion
1.21% of portfolio
|
Q2 2025
Added 64.64%
|
|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
3,165,263
shares
|
$1.76 Billion
0.3% of portfolio
|
Q2 2025
Reduced 20.65%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,465,054
shares
|
$1.37 Billion
0.09% of portfolio
|
Q2 2025
Reduced 0.18%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
2,313,496
shares
|
$1.29 Billion
0.34% of portfolio
|
Q2 2025
Added 1.62%
|
|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
1,966,018
shares
|
$1.09 Billion
0.16% of portfolio
|
Q2 2025
Added 1.41%
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
1,941,070
shares
|
$1.08 Billion
1.32% of portfolio
|
Q2 2025
Added 18.65%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,287,663
shares
|
$717 Million
0.05% of portfolio
|
Q2 2025
Added 2.93%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,220,359
shares
|
$679 Million
0.05% of portfolio
|
Q2 2025
Added 16.87%
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
1,210,735
shares
|
$674 Million
1.46% of portfolio
|
Q4 2023
Added 2.05%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
1,196,479
shares
|
$666 Million
0.08% of portfolio
|
Q2 2025
New holding
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
1,075,824
shares
|
$599 Million
0.1% of portfolio
|
Q2 2025
Added 26.46%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
958,569
shares
|
$533 Million
0.07% of portfolio
|
Q2 2025
Reduced 4.31%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
938,500
shares
|
$522 Million
1.07% of portfolio
|
Q2 2025
Added 69.47%
|
|
|
Amundi
Paris, I0 |
Aug 13, 2025 Q2 2025 |
897,131
shares
|
$499 Million
0.17% of portfolio
|
Q2 2025
Reduced 44.07%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
860,441
shares
|
$479 Million
0.09% of portfolio
|
Q2 2025
Reduced 8.5%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
841,549
shares
|
$468 Million
0.13% of portfolio
|
Q2 2025
Added 55.26%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
796,206
shares
|
$443 Million
0.06% of portfolio
|
Q2 2025
Reduced 4.88%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
777,469
shares
|
$433 Million
0.33% of portfolio
|
Q2 2025
Added 34.3%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
766,444
shares
|
$427 Million
0.05% of portfolio
|
Q2 2025
Reduced 64.76%
|
|
|
Legal & General Group PLC
London, X0 |
Aug 12, 2025 Q2 2025 |
739,581
shares
|
$412 Million
0.1% of portfolio
|
Q2 2025
Reduced 1.0%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
720,273
shares
|
$401 Million
0.07% of portfolio
|
Q2 2025
Added 1.4%
|